Skip to main content

The impact of provider restrictions on abortion-related outcomes: a synthesis of legal and health evidence

Abstract

Many components of abortion care in early pregnancy can safely be provided on an outpatient basis by mid-level providers or by pregnant people themselves. Yet, some states impose non-evidence-based provider restrictions, understood as legal or regulatory restrictions on who may provide or manage all or some aspects of abortion care. These restrictions are inconsistent with the World Health Organization’s support for the optimization of the roles of various health workers, and do not usually reflect evidence-based determinations of who can provide abortion. As a matter of international human rights law, states should ensure that the regulation of abortion is evidence-based and proportionate, and disproportionate impacts must be remedied. Furthermore, states are obliged take steps to ensure women do not have to undergo unsafe abortion, to reduce maternal morbidity and mortality, and to effectively protect women and girls from the physical and mental risks associated with unsafe abortion. States must revise their laws to ensure this. Where laws restrict those with the training and competence to provide from participating in abortion care, they are prima facie arbitrary and disproportionate and thus in need of reform. This review, developed by experts in reproductive health, law, policy, and human rights, examined the impact of provider restrictions on people seeking abortion, and medical professionals. The evidence from this review suggests that provider restrictions have negative implications for access to quality abortion, contributing inter alia to delays and recourse to unsafe abortion. A human rights-based approach to abortion regulation would require the removal of overly restrictive provider restrictions. The review provides evidence that speaks to possible routes for regulatory reform by expanding the health workforce involved in abortion-related care, as well as expanding health workers' roles, both of which could improve timely access to first trimester surgical and medical abortion, reduce costs, save time, and reduce the need for travel.

Plain language summary

This review identifies evidence of the impacts of provider restrictions on people seeking to access abortion and on abortion providers. It pursues a methodology designed to ensure the full integration of public health and human rights standards developed by the research team and published elsewhere. The evidence from this review points clearly to provider restrictions having negative implications for health outcomes, health systems, and human rights. This is especially important as international guidance provided by the WHO indicates best practice in provision and management of abortion and shows clearly that undue provider restrictions are not justified by reference to the nature and complexity of abortion.

Peer Review reports

Introduction

Many components of abortion care in the first trimester can safely be provided on an outpatient basis by mid-level providers or by pregnant people themselves. Yet, some states impose provider restrictions [1], understood as legal or regulatory restrictions on who may provide all or some aspects of abortion care. These restrictions are arbitrary: they are inconsistent with the World Health Organization’s (WHO) support for the optimization of the roles of various health workers [2, 3], and do not usually reflect evidence-based determinations of who can provide abortion.

Expanding the role of health workers involved in abortion care can increase the availability and accessibility of quality abortion care and lead to the better enjoyment of the internationally protected right to sexual and reproductive health ([4], para 12). Since its foundation, the WHO has recognized that “[t]he enjoyment of the highest attainable standard of health is one of the fundamental rights of every human being” [5], and human rights are integrated into its work.

International human rights law increasingly reflects the proposition that the availability and accessibility of abortion—rather than “mere” legality—is of critical importance ([6], para 8) to ensuring the effective realization of a wide range of reproductive rights, including the rights to privacy, life, security of person, and freedom from torture, cruel, inhuman and degrading treatment or punishment. As a matter of international human rights law, states should ensure that the regulation of abortion is evidence-based (i.e. not arbitrary) and proportionate (i.e. provided for by law, necessary for and rationally connected to the achievement of a legitimate objective that is pursued through the regulation, and minimally intrusive) ([7], para 18). Disproportionate impacts must be remedied ([8], para 8). Where laws restrict those with the training and competence to provide from participating in abortion care, they are prima facie arbitrary and disproportionate.

The aim of this review is to address knowledge gaps related to the health and non-health outcomes of provider restrictions through the effective synthesis of both human rights standards and evidence from existing studies using a methodology for integrating human rights in guideline development that has been described elsewhere [9]. This methodology is well-suited to interventions that are complex and can have multiple components interacting synergistically or dissynergistically, may be non-linear in their effects, and are often context dependent [10]. Such complex interventions often interact with one another, such that outcomes related to one individual or community may be dependent on others, and may be impacted positively or negatively by the people, institutions and resources that are arranged together within the larger system in which they are implemented [10]. This review is one of seven such reviews that were carried out as part of developing the evidence base for the WHO’s new consolidated Abortion Care Guideline (2022) [11].

Throughout this review we use the terms women, girls, pregnant women [and girls], pregnant people, and people interchangeably to include all those with the capacity for pregnancy.

Methods

Identification of manuscripts and data extraction

This review examined the impact of provider restrictions on two populations (i) people seeking abortion, and (ii) medical professionals. The search strategy was developed together with experts working in the fields of law, policy and human rights. It included the key words ‘abortion AND provider restriction’, ‘abortion AND provider regulation’, ‘abortion AND healthcare providers’. The search strategy is included in Additional file 1: Appendix S1. We searched the databases PubMed, HeinOnline, and JStor and the search engine Google Scholar. We looked for new evidence that was not included in the last update of the WHO guidelines: we therefore limited our search from 2010 through July 2021. Only manuscripts that undertook original data collection or analysis were included; we included quantitative studies (comparative and non-comparative), qualitative and mixed-methods studies, reports, PhD theses, and economic or legal analyses. Recognising that country experiences of provider restrictions may provide evidence about their impacts on abortion-related outcomes, no geographic limitations were imposed.

The full review team comprised of 6 members (MF, AF, FdL, AC, MR and AL). Two reviewers (MF and AF) conducted an initial screening of the literature. Titles and abstracts were first screened for eligibility using the Covidence® tool [12]; full texts were then reviewed. We restricted our analysis to English language outputs only. A third reviewer (FdL) confirmed that these manuscripts met inclusion criteria. Two reviewers (FdL and AC) extracted data. Any discrepancies were reviewed and discussed with two additional reviewers (AL and MR). The review team resolved discrepancies through consensus.

Our outcomes of interest included both health and non-health outcomes that, based on a preliminary assessment of the literature [13], could be linked to the effects of the provider regulation intervention. Our a priori outcomes included delayed abortion, opportunity costs, self-managed abortion, workload implications, system costs, perceived imposition on personal ethics or conscience, perceived impact on relationship with patient, referral to another provider, unlawful abortion, continuation of pregnancy, or stigmatization. A preliminary human rights analysis was also undertaken, drawing on the international human rights corpus on reproductive rights [9].

In order to fully understand the implications of the findings for abortion law and policy, we applied human rights standards to the data extracted from these manuscripts. The applicable standards from human rights law were drawn from a careful review of the corpus of international human rights law in accordance with the approach outlined elsewhere [9]. They thus exclude regional and national human rights laws. The applicable standards were considered together with the evidence from the included manuscripts in order to identify, (a) which human rights standards are engaged by provider restrictions, (b) whether this evidence suggests that provider restrictions have positive or negative effects on the enjoyment of rights, and (c) where no data is identified from the manuscripts against outcomes of interest, whether human rights law provides evidence that can further elucidate the impacts and effects of provider restrictions. This is summarized in Tables 2 and 3 below.

Analysis

We matched data from included studies to the outcomes of interest and presented this in evidence tables. In these tables, the association of each finding on the outcome was presented, as well as an overall conclusion of the identified findings across the body of evidence. We then applied human rights standards to these outcomes to develop an understanding of the effects of provider restrictions that combines the evidence from human rights law (i.e. the applicable human rights standards) and the included studies. To summarize the effect of the intervention, across all study designs, we used and applied a visual representation of effect direction. The direction of the evidence was illustrated by a symbol which indicated whether, in relation to that particular outcome, the evidence extracted from a study suggested an increase (▲), decrease (), or no change in the outcome (). The symbol did not indicate the magnitude of the effect [9].

Results

The search generated 27,480 citations after duplicates were removed. We screened the titles and abstracts and conducted a full text screening of 389 manuscripts. We excluded those manuscripts that did not have a clear connection with the intervention and our pre-defined outcomes, resulting in 9 manuscripts being included in the final analysis (Fig. 1. Prisma flow diagram).

Fig. 1
figure 1

PRISMA Flow diagram

Manuscripts described data from four countries: Australia [14, 15], Ethiopia [16, 17], Nepal [18] and the United States [15, 19,20,21,22]. The characteristics of included manuscripts are presented in Table 1. The included studies contained information relevant for the outcomes: delayed abortion [19,20,21]; opportunity costs [15, 16, 18,19,20,21,22]; self-managed abortion [16]; system costs [2, 14, 19, 21, 22]; workload implications [14, 17,18,19,20, 22]; perceived imposition on personal ethics or conscience [20]; and perceived impact on relationship with patient [20]. No evidence was identified linking the intervention to the outcomes: referral to another provider; unlawful abortion; continuation of pregnancy; or stigmatization.

Table 1 Characteristics of included studies

Impact of the intervention on abortion seekers

A summary of the impacts of the intervention on abortion seekers and the application to human rights are presented in Table 2. Evidence identified per study and outcome are presented in Additional file 2: Tables S1 and S2. The evidence from three studies [19,20,21] suggests that provider restrictions contribute to delayed abortion by demonstrating how expansion of health workers’ roles improve timely access to care [19] and by showing how requiring a specific provider, who must also undertake mandated scripted counselling, imposes logistical and administrative burdens which in turn may lead to delayed abortion [20, 21]. Provider restrictions that do not reflect the evidence on who has the necessary skills to provide quality abortion [11] and which produce or contribute to delays in accessing abortion are likely arbitrary and disproportionately interfere with the human rights of pregnant people. In particular they suggest non-compliance with states’ obligation to respect, protect and fulfil the right to life and the right to health, and particularly the obligation to take steps to reduce maternal mortality and morbidity ([6], para 8; [23], paras 6, 9, 24, 30–33), and to ensure that, where it is lawful, abortion is safe and accessible ([6], para 8).

Table 2 Impact of PR on the abortion seeker (A + B + C)

Findings from seven studies [15, 16, 18,19,20,21,22] suggest that provider restrictions increase opportunity costs including increased financial cost, travel time and associated costs, waiting times, additional clinic contacts, emotional distress for abortion seekers, and undesired surgical interventions. These opportunity costs again point to potential incompatibility with human rights, including the right to equality and non-discrimination in sexual and reproductive health. Four studies [15, 16, 18, 19] provide evidence on the positive effects of expanded health worker roles, which include reduced costs, need for travel and waiting times, and improved access to abortion.

One study [16] found that provider restrictions may limit access to care and contribute to unsafe self-managed abortions. International human rights law includes an obligation on states to take steps to reduce maternal mortality and morbidity and to protect people seeking abortion including from the physical and mental risks associated with unsafe abortion ([6], para 8). While self-managed abortion is not inevitably unsafe, the state is obliged to ensure that its regulatory choices—including provider restrictions—do not force women to resort to unsafe abortion and, if necessary, to review, reform and liberalize its laws to achieve this ([8], para 28). Considered alongside human rights law, these studies thus suggest that provider restrictions that do not reflect the evidence on who has the necessary skills to provide quality abortion [11] result in disproportionate interferences with the rights of people seeking abortion.

Impact of provider restrictions on health professionals

A summary of the impacts of the intervention on health professionals and the application of human rights are presented in Table 3. Evidence identified per study and outcome are presented in Additional file 2: Tables S1 and S2. Evidence from six studies [14, 17,18,19,20, 22]; suggests that provider restrictions have workload implications for healthcare professionals. These include issues such as sustainability of staffing, logistical and financial costs, organizational changes, increased workload, and stress experienced by medical professionals. The process of expanding health worker roles involves challenging the traditional division of labour [14, 17] and could require changes to staffing and logistics and increased costs in the short term [19]. Workload implications of this kind may result in persons or facilities not providing abortion care or arranging care only in very constrained ways (e.g., one day a week or similar) so that, in reality, access to abortion is obstructed by provider restrictions. States’ obligation to respect, protect and fulfil the right to the highest attainable standard of physical and mental health includes an obligation to ensure sexual and reproductive health care is available, accessible, acceptable and of good quality ([4], paras 8, 12). These studies suggest that the impact of provider restrictions that do not reflect the evidence on who has the necessary skills to provide quality abortion [11] may be to make abortion less available and accessible, and thus be inconsistent with human rights.

Table 3 Impact of PR on the abortion provider (A + B + C)

One study [20] provided evidence on the impact of the intervention on the outcomes, perceived imposition on personal ethics or conscience, and perceived impact on the provider-patient relationship. This study showed that where the law requires provision by a specific provider, who must also undertake mandated scripted counselling, the professionals perceive this to be an unreasonable intrusion into the practice of medicine and as having a negative impact on the provider-patient relationship. Thus, as well as arguably imposing on the health worker’s right to freedom of conscience or belief, such restrictions may reduce the quality of sexual and reproductive health care that pregnant people receive and thus be inconsistent with the right to the highest attainable standard of physical and mental health.

Discussion

The evidence from this review suggests that provider restrictions have implications for access to quality abortion. The right to sexual and reproductive health obliges states to ensure that health-care facilities, goods and services are available, accessible, acceptable and of good quality ([4], paras 8, 12), which the evidence from this review suggests is undermined by provider restrictions. Furthermore, although there are some exceptions [24], the rate at which physicians and other healthcare providers tend to take up opportunities for abortion training where they are available is low [25], training in surgical abortion provision is not always a requirement of qualification [26], and there are often shortcomings in abortion training provided in obstetrics and gynaecology training contexts [27]. Given this, any regulatory approaches that may reduce the number of willing providers with foreseeable implications for the availability and accessibility of abortion require significant justification on the part of the state and raise questions of human rights compliance.

International human rights law requires states to take steps to ensure women do not have to undergo unsafe abortion ([28], para 10), to reduce maternal morbidity and mortality, and to effectively protect women and girls from the physical and mental risks associated with unsafe abortion ([6], para 8; 28, para 10). States must revise their laws to ensure this ([6]; 28, para 10; [29], para 44). In practice, this means that the regulation of abortion must not jeopardize women’s lives, subject women or girls to physical or mental pain or suffering constituting torture or to cruel, inhuman or degrading treatment or punishment, discriminate against women or girls, or interfere arbitrarily with their privacy ([6], para 8). Given the evidence presented in this review suggesting that provider restrictions contribute to delays and recourse to unsafe abortion, a human rights-based approach to abortion regulation would require the removal of overly restrictive provider restrictions. The review also provides evidence that speaks to possible routes for regulatory reform by expanding the health workforce involved in abortion related care, as well as expanding health workers roles, both of which could improve timely access to first trimester surgical and medical abortion, reduce costs, save time, and reduce the need for travel [19]. Among the WHO’s core functions are “shaping the research agenda and stimulating the generation, translation, and dissemination of valuable knowledge” and “setting norms and standards, and promoting and monitoring their implementation” [30]. Accordingly, the Abortion Care Guideline is “intended to provide concrete information and guidance…for national and subnational policy-makers, implementers and managers…members of nongovernmental organizations and other civil society organizations and professional societies…health workers and other stakeholders” ([11], p. 3) to support an enabling environment for quality abortion. Among the components of an enabling environment is respect for human rights including a supportive framework for law and policy ([11], p. 5) in which non-clinical barriers to abortion are removed. The Guideline accordingly recommends against regulation of who can provide and manage abortion (i.e. provider restriction) that is inconsistent with WHO guidance ([11], p. 59).

It is further important to note that in many settings provider restrictions interact with other abortion laws and policies, which may compound their effects. For example, where abortion is criminalized (i.e. where abortion is contained in penal codes or criminal laws, other offences are applied to abortion-related activity, or there are criminal penalties for having, assisting with, providing information about, or providing abortion) provider restrictions indicate boundaries of criminal liability. In other words, provision by a specified provider is lawful while provision by a non-specified provider is unlawful. The combined effect of these regulatory interventions (provider restrictions plus criminalization) can be to create ‘chilling effects’ for healthcare professionals who may be unwilling to engage in abortion care provision in case of incurring criminal liability. The negative human rights implications of criminalization are widely recognized by regional human rights courts and treaty monitoring bodies ([6], para 8; [8], paras 20, 34; 28; [31], para 18; [32], para 51(l); [33], para 60; [34], paras 79–83, 107; [28], para 20; [35]), and form part of the broader regulatory context in which interventions such as provider restrictions must be understood.

Limitations

This review has limitations. It is limited in geographic scope, with papers relating to just four settings (Australia, Ethiopia, Nepal and United States of America (USA)), and in some cases only to the law in sub-national jurisdictions (the states of California (USA), Illinois (USA) and Victoria (Australia)). This review also only contains manuscripts published in English. Further research on the impact of provider restrictions in a wider range of settings would be welcome. Furthermore, the realization of human rights applicable to abortion-related interventions is not a research area that readily lends itself to randomized controlled trials or comparative observational studies; rather, studies are often conducted without comparisons. While this may be considered a limitation from a standard methodological perspective for systematic reviews, it does not limit the ability to identify human rights-related implications of law and policy interventions. Additionally, standard tools for assessing risk of bias or quality, including GRADE [36], were unsuitable for our review, given the objective of fully integrating human rights standards into our understanding of the effects of provider restrictions as a regulatory intervention. Thus, it was necessary to review and include a wide range of evidence from legal analyses to clinical studies. Finally, and consistent with the methodological approach pursued [9], this review applies international, rather than regional or domestic, human rights law to develop a general understanding of the rights-related implications of provider restrictions. The applicability of any individual human rights standard in a specific setting will depend on factors including the state’s ratification of relevant human rights instruments and their status in domestic law ([11], p. 7).

Conclusion

This review identified evidence of the impacts of provider restrictions on people seeking to access abortion and on abortion providers. When considered alongside international human rights law, this evidence pointed clearly to impacts that have negative implications for health outcomes, health systems, and human rights. This is especially so as international guidance provided by the WHO indicates best practice in provision and management of abortion and shows clearly that undue provider restrictions are not justified by reference to the nature and complexity of abortion [2, 3, 11]. Given this, and as international human rights law enjoins evidence-based regulation, where they exist, provider restrictions should operate to maximize health outcomes, health system efficiency, and human rights enjoyment.

Availability of data and materials

All data generated or analysed during this study are included in this published article and its Additional files.

Abbreviations

USA:

United States of America

WHO:

World Health Organization

References

  1. Lavelanet A, Johnson BR, Ganatra B. Global abortion policies database: a descriptive analysis of the regulatory and policy environment related to abortion. Best Pract Res Clin Obstet Gynaecol. 2020;62:25–35.

    Article  PubMed  Google Scholar 

  2. World Health Organization. Recommendations: optimising health worker roles to improve access to key maternal and newborn health interventions through task shifting. Geneva: World Health Organization; 2012.

    Google Scholar 

  3. World Health Organization. Health worker roles in providing safe abortion care and post-abortion contraception. Geneva: World Health Organization; 2015.

    Google Scholar 

  4. CESCR, General comment no. 14: The Right to the Highest Attainable Standard of Health (Article 12 of the International Covenant on Economic, Social and Cultural Rights) (2000) (UN Doc. E/C.12/2000/4). Geneva.

  5. World Health Organization, Constitution of the World Health Organization (1946). Geneva.

  6. HRC, General comment no. 36 on article 6 of the International Covenant on Civil and Political Rights, on the right to life (2018) (UN Doc. CCPR/C/GC/36). Geneva.

  7. UN Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health, Interim Report to the General Assembly (2011) (UN Doc. A/66/254). Geneva.

  8. CESCR, General comment no. 22 on the right to sexual and reproductive health (Article 12 of the International Covenant on Economic, Social and Cultural Rights) (2016) (UN Doc. E/C/12/GC/22). Geneva.

  9. de Londras F, Cleeve A, Rodriguez M, Lavelanet A. Integrating rights and evidence: a technical advance in abortion guideline development. BMJ Glob Health. 2021;6:e004141. https://doi.org/10.1136/bmjgh-2020-004141.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Petticrew M, Knai C, Thomas J, et al. Implications of a complexity perspective for systematic reviews and guideline development in health decision making. BMJ Glob Health. 2019;4: e000899. https://doi.org/10.1136/bmjgh-2018-000899.

    Article  PubMed  PubMed Central  Google Scholar 

  11. World Health Organization, Abortion care guideline (2022). Geneva.

  12. Innovation VH. Covidence systematic review software. In: Melbourne, Australia. www.covidence.org.

  13. Burris S, Ghorashi A, Fostercloud L, Rebouché R, Skuster P, Lavelanet A. Identifying data for the empirical assessment of law (IDEAL): a realist approach to research gaps on the health effects of abortion law. BMJ Glob Health. 2021;6:e005120.

    Article  PubMed  PubMed Central  Google Scholar 

  14. de Moel-Mandel C, Graham M, Taket A. Expert consensus on a nurse-led model of medication abortion provision in rural Victoria, Australia: a Delphi study. Contraception. 2019;100(5):380–5.

    Article  PubMed  Google Scholar 

  15. Grossman D, Goldstone P. Mifepristone by prescription: a dream in the United States but reality in Australia. Contraception. 2015;92(3):186–9.

    Article  PubMed  Google Scholar 

  16. Afework MH, et al. Acceptability of the involvement of health extension Workers (HEWS) in Medical Abortion (MA): the perspectives of clients, service providers and trained HEWS in East Shoa and Arsi Zones, Oromiya Region, Ethiopia. Ethiop Med J. 2015;53(1):25–34.

    PubMed  Google Scholar 

  17. Bridgman-Packer D, Kidanemariam S. The implementation of safe abortion services in Ethiopia. Int J Gynaecol Obstet. 2018;143(Suppl 4):19–24.

    Article  PubMed  Google Scholar 

  18. Anderson K, et al. Expansion of safe abortion services in nepal through auxiliary nurse-midwife provision of medical abortion, 2011–2013. J Midwifery Womens Health. 2016;61(2):177–84.

    Article  Google Scholar 

  19. Battistelli MF, Magnusson M, Biggs A, Freedman L. Expanding the abortion provider workforce: a qualitative study of organizations implementing a New California policy. Perspect Sex Reprod Health. 2018;50(1):33–9.

    Article  PubMed  Google Scholar 

  20. Mercier R, Buchbinder M, Bryant A, Britton L. The experiences and adaptations of abortion providers practising under a new TRAP law: a qualitative study. Contraception. 2015;91(6):507–12.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Srinivasulu S, Yavari R, Brubaker L, Riker L, Prine L, Rubin S. US clinicians’ perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care. Contraception. 2021;104(1):92–7.

    Article  CAS  PubMed  Google Scholar 

  22. Rasmussen K, Janiak E, Cottrill A, Stulberg D. Expanding access to medication abortion through pharmacy dispensing of mifepristone: primary care perspectives from Illinois. Contraception. 2021;104(1):98–103.

    Article  PubMed  Google Scholar 

  23. Committee on the Rights of the Child, General comment no. 4 on adolescent health and development in the context of the Convention on the Rights of the Child (2003) (UN Doc. CRC/GC/2003/4). Geneva.

  24. Costescu D, Guilbert E, Duschene E, Blacke J. Mifepristone ready: uptake of mifepristone medical abortion training in Canada. J Obstet Gynaecol Can. 2019;41(5):715.

    Article  Google Scholar 

  25. Jackson C, Foster A. Ob/Gyn training in abortion care: results from a national survey. Contraception. 2012;86(4):407–12.

    Article  PubMed  Google Scholar 

  26. Babra DS, Lyus R, Black B, et al. Development of a national referral centre for surgical abortion at Homerton University Hospital. BMJ Sex Reprod Health. 2019;45:305–8.

    Article  Google Scholar 

  27. Steinauer JE, et al. Abortion training in US obstetrics and gynecology residency programs. Am J Obstet Gynecol. 2018;219(1):86.

    Article  PubMed  Google Scholar 

  28. HRC General comment no. 28(68), article 3 Equality of Rights between Men and Women (article 3) (2000) (UN Doc. CCPR/C/21/Rev.1/Add.10). Geneva.

  29. Report to the Human Rights Council of the UN Special Rapporteur on Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment (2016) (UN Doc A/HRC/31/57).

  30. World Health Organization, Thirteenth General Programme of Work 2019–2023 (2019)

  31. CEDAW, General recommendation No. 35 on gender-based violence against women, updating general recommendation No. 19 (2017) (UN Doc. CEDAW/C/GC/35).

  32. CEDAW: General recommendation No. 33 on women’s access to justice (2015) (UN Doc. CEDAW/C/GC/33).

  33. Committee on the Rights of the Child, General comment no. 20 on the implementation of the rights of the child during adolescence (2016) (UN Doc. CRC/C/GC/20*)

  34. Report of the UN Working Group on the Issue of Discrimination against Women in Law and in Practice (2016) (UN Doc. A/HRC/32/44)

  35. A, B and C v Ireland [2010] ECHR 2032 (European Court of Human Rights)

  36. Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices 1. Introduction. BMJ. 2016;353:i2016.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the UNDP‐UNFPA‐UNICEF‐WHO‐World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (WHO). Professor de Londras also acknowledges the support of the Leverhulme Trust through the Philip Leverhulme Prize.

Author information

Authors and Affiliations

Authors

Contributions

AL and FdL developed the PICOs and search strategies. AF and MF did the initial searches. AL, AC, MR and FdL reviewed and finalised data extraction and quality. FdL did the initial manuscript draft. AL prepared the tables and figures. All authors reviewed, finalised and approved the submitted text. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Fiona de Londras.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Search strategy.

Additional file 2:

Table S1. Impact on the intervention on abortion seekers. Table S2. The impact of the intervention on health professionals

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Londras, F., Cleeve, A., Rodriguez, M.I. et al. The impact of provider restrictions on abortion-related outcomes: a synthesis of legal and health evidence. Reprod Health 19, 95 (2022). https://doi.org/10.1186/s12978-022-01405-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12978-022-01405-x

Keywords